Skip to main content
logo
Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
5.44
-0.04 (-0.73%)
At close: Feb 20, 2026, 4:00 PM EST
5.52
+0.08 (1.47%)
After-hours: Feb 20, 2026, 7:25 PM EST

Nuvation Bio Revenue

Nuvation Bio had revenue of $13.12M in the quarter ending September 30, 2025, with 1,704.68% growth. This brings the company's revenue in the last twelve months to $26.75M, up 1,137.19% year-over-year. In the year 2024, Nuvation Bio had annual revenue of $7.87M.

Revenue (ttm)
$26.75M
Revenue Growth
+1,137.19%
P/S Ratio
69.73
Revenue / Employee
$91,918
Employees
291
Market Cap
1.87B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20247.87M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sarepta Therapeutics2.41B
Innoviva388.52M
Aurinia Pharmaceuticals265.81M
Vericel258.72M
Stoke Therapeutics205.63M
Agios Pharmaceuticals54.03M
Recursion Pharmaceuticals43.69M
Revenue Rankings

NUVB News

More News